HDAC6 and central nervous system cancer: We next examined whether the effects of HDAC6 inhibitors on glioma cilia extend to normal neural cell types that harbor aaTub+ and ARL13B+ cilia, such as radial glial cells and GFAP+ astrocytes [26,31,32,33].